All Access

Health Tech Deals

Health Tech Deals Alerts

Alert

Standard

Health Tech Deals Thought Bubble

Thought Bubble

mustard

BFD Expert Voices - Health Tech Deals

BFD Expert Voices

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

jobs

transportation

business

stock-market-news

retail-news

crypto

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

pittsburgh

atlanta

san-diego

charlotte

boulder

washington-dc

kansas-city

dallas

denver

detroit

des-moines

austin

boston

chicago

cleveland

columbus

houston

indianapolis

miami

nashville

new-orleans

nw-arkansas

philadelphia

phoenix

portland

richmond

salt-lake-city

san-antonio

san-francisco

seattle

tampa-bay

twin-cities

raleigh

huntsville

colorado-springs

axios-local

axios-pro

axios-live

the-axios-show

Former Olive AI president Jeremy Friese has raised $25 million for prior authorization startup Humata Health, he tells Axios exclusively.

Why it matters: After selling a former iteration of Humata (Verata) to now-shuttered health tech unicorn Olive AI in 2020, Friese is at it again with what one investor calls "Verata 2.0."

Zoom in: Blue Venture Fund and LRVHealth led the unlabeled round.

Optum Ventures, .406 Ventures, Highmark Ventures, and VentureforGood participated.

Funds will go to fuel Humata's expansion from the provider to the payer side of the health care market.

Friese declined to say when Humata would raise next but said the company was profitable.

How it works: Winter Park, Florida-based Humata is built on the backbone of Friese's former prior authorization (PA) startup Verata Health, which Olive AI acquired in 2020 for a reported $120 million.

Humata last fall bought back those assets.

The company today is "a combination of what we've built and acquired," per Friese, "and we've improved the technology."

That technology connects to the electronic medical record to help automate the entire PA process, identifying the medical necessity rules and the documentation that meets them, "so that just like my high school son can show his work in algebra, we show it to our customers, who then submit it," Friese says.

What they're saying: "Prior authorization represents in our minds a point at which there's a high degree of friction for payers and providers ... and eventually a point at which they can agree," says LRVHealth managing partner Tripp Peake, whose firm was also an investor in Verata.

"You think of a point at which you could get to something like an automated handshake" with technology like what Humata provides, he adds.

Friese brought learnings from his Verata experience and, "as he started Humata, I think he was getting at Verata 2.0.," Peake says. 

The latest: Humata has 25 health system customers, including Highmark and Allegheny Health System, per Friese.

Driving the news: The Centers for Medicare and Medicaid Services (CMS) in January required insurers to speed prior authorization decisions, setting timelines of 72 hours for urgent requests and seven calendar days for standard requests.

And Congress last week mandated Medicare Advantage plans to create electronic PA systems to streamline coverage decisions.

Between the lines: In response to surveys compiled for a 2021 report by the Medical Group Management Association, 91% of providers said the overall regulatory burden on their practices rose over the past year.

And they identified PAs as the worst part.

State of play: Prior authorizations are one piece of a complex health care administration puzzle that dozens of startups are attempting to tackle with AI.

Anterior (FKA Co:Helm), an AI-powered health care administration startup, last week raised a $20 million Series A.

Health payments software company Waystar this month went public at $968 million, the best showing the health tech sector has seen since 2022.

Cohere Health, a prior authorization automation company, in February raised an unlabeled $50 million.

Waystar this month went public at $968 million

Exclusive: Ex-Olive exec raises $25M for automation startup Humata Health

Florida-based Humata is built on the backbone of Friese's former startup, Verata Health.

Illustration of a shadow about to sign off on the health symbol. 

Health tech deals

Former Olive AI president Jeremy Friese has raised $25 million for prior authorization startup Humata Health, he tells Axios exclusively.Why it matters: After selling a former iteration of Humata (Verata) to now-shuttered <a class="gtmContentClick" data-vars-link-text="health tech unicorn Olive AI" data-vars-click-url="https://www.axios.com/pro/health-tech-deals/2022/04/05/4-billion-health-tech-startup-olive-overpromises-and-underdelivers" data-vars-content-id="e55a0021-2a74-43cb-ae0b-354af1a35ce9" data-vars-headline="Exclusive: Ex-Olive exec raises $25M for automation startup Humata Health" data-vars-event-category="story" data-vars-sub-category="story" data-vars-item="in_content_link" href="https://www.axios.com/pro/health-tech-deals/2022/04/05/4-billion-health-tech-startup-olive-overpromises-and-underdelivers" target="_self">health tech unicorn Olive AI</a> in 2020, Friese is at it again with what one investor calls &quot;Verata 2.0.&quot;

Exclusive: Ex-Olive exec raises $25M for automation startup Humata Health

What to read next